Sort   by:  
 Page size 
UnknownIntegrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines.
Not available
S-EPMC6481945 | biostudies-literature
UnknownGanitumab (AMG 479) inhibits IGF-II-dependent ovarian cancer growth and potentiates platinum-based chemotherapy.
Not available
S-EPMC4138720 | biostudies-literature
UnknownZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer.
Not available
S-EPMC11968244 | biostudies-literature
UnknownEarly Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers.
Not available
S-EPMC11726017 | biostudies-literature
UnknownRucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Not available
S-EPMC5901715 | biostudies-literature
UnknownLenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Not available
S-EPMC11651366 | biostudies-literature
UnknownGWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
Not available
S-EPMC3693183 | biostudies-literature
UnknownDevelopment and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).
Not available
S-EPMC7572656 | biostudies-literature
UnknownEpigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
Not available
S-EPMC3848248 | biostudies-literature
UnknownIdentification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Not available
S-EPMC3709460 | biostudies-literature
Sort   by:  
 Page size